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Vascular Remodeling in the Internal Mammary Artery
Graft and Association With In Situ Endothelin-1 and
Receptor Expression
Allison J. Sutherland, BSc (Hons), PhD; Maria I. Nataatmadja, MDSc, PhD;
Philip J. Walker, MBBS, FRACS; Leila Cuttle, BSc (Hons); R. Bruce Garlick, MBBS (Hons), FRACS;
Malcolm J. West, MBBS, PhD, FRACP
Background—The vasoconstricting peptide endothelin-1 (ET-1) has been associated with atherosclerotic cardiovascular
disease, vascular smooth muscle cell (VSMC) growth stimulation, and intimal thickening. ET-1 binds 2 receptor
subtypes, endothelin A and B, and the ETA receptor mediates vasoconstriction and VSMC growth. This study aims to
quantitatively assess arterial remodeling variables and compare them with changes in ET-1, ETA, and ETB expression
in the internal mammary artery (IMA).
Methods and Results—Specimens from 55 coronary artery disease (CAD) patients (45 men, 10 women; mean age 65
years) and 14 control IMA specimens (from 7 men and 7 women; mean age 45 years) were collected. IMA cross sections
were assessed by histochemical and immunohistochemical staining methods to quantify the levels of medionecrosis,
fibrosis, VSMC growth, ET-1, ETA, ETB, and macrophage infiltration. The percentage area of medionecrosis in the
patients was almost double that in the controls (31.8514.52% versus 17.109.96%, P0.0006). Total and type 1
collagen was significantly increased compared with controls (65.818.3% versus 33.713.7%, P0.07, and
14.210.0% versus 4.82.8%, P0.01, respectively). Despite ACE and/or statin therapy, ET-1 expression and cell
cycling were significantly elevated in the patient IMAs relative to the controls (46.2718.46 versus 8.568.42,
P0.0001, and 37.2912.88 versus 11.068.18, P0.0001, respectively). ETA and ETB staining was elevated in the
patient vessels (46.8811.52% versus 18.587.65%, P0.0001, and 42.987.08% versus 34.735.20%, P0.0067,
respectively). A mild presence of macrophages was noted in all sections.
Conclusions—Elevated distribution of collagen indicative of fibrosis coupled with increased cell cycling and high levels
of ET-1 and ETA expression in the absence of chronic inflammation suggests altered IMA VSMC regulation is
fundamental to the remodeling process. (Circulation. 2006;113:1180-1188.)
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The internal mammary artery (IMA) is a small vessellocated in the thoracic cavity that branches off the
subclavian artery. It is unusual with respect to its histo-
logical character in that it has the features both of an
elastic and of a muscular artery and has therefore been
referred to as a transition artery. Previous histological
reports on IMA structure indicated that the media consists
of a network of circularly and longitudinally interlacing
elastic lamellae, in which vascular smooth muscle cells
(VSMCs) are dispersed and circumferentially arranged.1
Because of these attributes, the IMA is considered to be
less prone to intimal hyperplasia than muscular arteries
and veins and is currently the most preferable conduit for
coronary revascularization surgery. It functions well as a
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conduit, with patency rates between 85% and 95%2 at least 10
years postoperatively.
Despite the fact that this vessel has a much higher patency
than other vascular grafts used for CABG surgery,3 it is not
considered a passive conduit and is sometimes limited in
function owing to poor flow and the fact that it is susceptible
to perioperative spasm4 mediated by vasoconstrictors such as
endothelin (ET)-1. Investigating the effects of endothelin on
IMA graft specimens, Verma and colleagues5 demonstrated
that the endothelin receptor antagonist bosentan improved the
vasodilatory function of the IMA, albeit in an experimental
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group that appeared to have an unusually low response to
acetylcholine compared with other studies of similar design.6
In a histological study, Göbel et al7 observed medial ET-1
immunoreactivity in 89% of IMA biopsy samples from
CABG patients. This group observed that the amount of ET-1
staining was significantly higher in patients with hypercho-
lesterolemia and non–insulin-dependent diabetes mellitus
than in those without these risk factors. Furthermore, Rossi et
al8 demonstrated that individuals with hypertension or coro-
nary artery disease (CAD) had increased levels of
preproET-1, endothelin-converting enzyme-1 mRNA, and
ET-1 immunoreactivity in the IMA. In particular, they noted
significant correlations between ET-1 immunoreactivity in
the tunica media and mean blood pressure, cholesterol, and
the number of atherosclerotic sites. It was also suggested that
in contrast to endothelial ET-1, which is subject to short-term
regulation, the presence of ET-1 in the media contributes a
more important and stable source.
ET-1 binds 2 G-protein–coupled receptors: endothelin A
(ETA) and B (ETB). In both atherosclerotic and nondiseased
coronary artery, ETA receptors are far more dominant in
VSMCs of the tunica media than the ETB subtype.9 In
experimental vein grafts, Dashwood et al,10 using autoradi-
ography, observed greater proportions of ETA relative to ETB
present in the tunica media and neointima. Dagassan and
colleagues11 compared the densities of both endothelin recep-
tor subtypes in cardiomyopathic hearts and observed that ETA
was significantly more prevalent in the vessel media (83%
versus 17%, respectively); however, in atherosclerotic coro-
nary arteries, levels of ETA and ETB receptor binding were
comparable (51% versus 49%, respectively).
In addition to its role in advanced atherosclerotic disease,
ET-1 is known to participate in preatherogenic changes
within the vasculature at a cellular and molecular level.
ET-1–stimulated collagen deposition has been documented in
the heart, intracardiac arteries,12 and aorta13 and has been
reversed with a specific ETA receptor antagonist. Tharaux et
al14 observed that in renal microvessels, when nitric oxide
production was suppressed, ET-1 synthesis was increased and
was associated with accumulation of collagen type 1. More-
over, ET-1 has also been shown to stimulate DNA synthesis
in various quiescent VSMC lines,15,16 in which peptide
expression is especially strong during the S phase, when cells
produce new DNA. Azuma et al17 noted increased ET-1
immunoreactivity 24 and 72 hours after balloon angioplasty
in the rabbit carotid artery, in which an increase in cells
labeled with proliferating cell nuclear antigen (PCNA, a
diagnostic S-phase growth marker) was also apparent.
This investigation aimed to assess the IMA histological
profile and quantitatively measure vascular wall remodeling,
including changes in extracellular matrix composition and
VSMC proliferation in conjunction with the presence of in
situ ET-1, ETA, and ETB expression in CABG patients and
control IMA specimens. Although the IMA is a sound graft,
this study focuses on the pathological role of ET-1 and
receptors in abnormal vessel wall remodeling, and as such, it
essentially used the IMA as an in situ model. Giannoukas and
colleagues18 have demonstrated that ultrasound evaluation
and histology of the long saphenous vein do not correlate and
have shown that ultrasound was only effective in detecting
10% of moderate/severe fibrosis in this vessel. This study is
novel in that it additionally evaluates structural and cellular
abnormalities in association with ET-1, a pathological and
potential preclinical marker of atherogenesis that is well
known for its association with endothelial dysfunction.
Methods
Tissue Source
Fifty-five ungrafted IMA (UIMA) segments were collected from
patients undergoing CABG surgery (45 men, 10 women; mean age
65 years). Fourteen IMA specimens, collected from organ donors (7
men and 7 women; mean age 45 years) were used as controls
(CIMA). None of the donors had coronary atherosclerotic disease,
hypertension, hyperlipidemia, or diabetes mellitus at the time of
death. Cause of death for the organ donors included acute head
trauma, subarachnoid hemorrhage, cerebral infarct, and subdural
hemorrhage. All CABG subjects gave written informed consent
before study participation, and likewise, the next of kin gave
permission for Queenslanders Donate to collect an artery specimen
for a cardiovascular research study. Approval for this project had
been conferred from the medical research ethics committees of The
Prince Charles Hospital (EC2126) and The University of Queensland
(clearance No. 2003000113) before commencement.
Histology and Immunohistochemistry
A section of the distal left UIMA, which was not required for left
anterior descending coronary artery grafting, was collected from all
CABG participants. In an additional 2 cases, a section from the
mid-distal left UIMA and proximal right UIMA was also discarded
during the surgical procedure and collected for research. A small
segment of the left distal IMA was harvested from the organ donors.
All specimens were fixed in 10% phosphate-buffered formalin and
were processed within 48 hours of fixation. Specimens were
paraffin-embedded, and 4-m serial cross sections were cut for all
staining procedures with the exception of Sirius red, for which 7-m
sections were used. Tissue sections were attached to Super Frost Plus
slides (Menzel Glaser GmbH, Braunschweig, Germany). Hematox-
ylin and eosin staining was used to examine vessel wall morphology,
Alcian Blue/Verhoeff’s van Gieson to identify areas of medionecro-
sis and elastic fibers, respectively,19,20 and Sirius red for assessment
of collagen content, specifically type 1 and type 3.21
Immunohistochemical labeling was used to assess cell growth
(PCNA; Dakocytomation, Glostrup, Denmark), ET-1/ETA/ETB ex-
pression (Sigma Aldrich, St Louis, Mo), and monocyte/macrophage
presence (CD68, Dakocytomation). After tissue sections were rehy-
drated and washed in Tris saline buffer (TBS, 1X), citrate heat
retrieval (0.1 mol/L citrate) was used to enhance epitope binding.
Endothelin receptor and CD68 antigen retrieval was performed with
0.8% and 0.4% pepsin in 0.1N HCl, respectively.
Sections were then washed in 0.1% sodium azide and 2% H2O2,
blocked with 4% powdered milk solution, and then incubated in 10%
normal goat serum. Primary antibody was diluted in TBS (ET-1
1:250; ETA and ETB 1:100; PCNA 1:50; CD68 1:100) and incubated
in a humidified chamber overnight at room temperature. Slides were
then incubated for 1 hour inclusive at room temperature with an
indirect peroxidase reaction with a biotinylated secondary antibody
(Jackson Immunoresearch Laboratories Inc, West Grove, Pa). Per-
oxidase activity was visualized after the addition of 3,3-
diaminobenzidine (Zymed, San Francisco, Calif). Sections were
lightly counterstained with Mayer’s hematoxylin, dehydrated with
ethanol and xylene, and mounted with DePx (BDH Laboratories,
Poole, England).
Histological Assessment and Quantitative
Image Analysis
The cellular remodeling variables (VSMC disorganization and inti-
mal hyperplasia) were semiquantitated and graded on a scale
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between 1 and 4 depending on pathological change. VSMC disor-
ganization was scored as follows: 1well-organized distribution and
alignment of VSMCs in the tunica media (Figure 1A); 2mild
VSMC disorganization without evidence of elastic lamellae or
internal elastic lamina disruption; 3moderate VSMC growth and
proliferation in the media in conjunction with increased loss and
fragmentation of elastic fibers (Figure 1B); or 4severe pathological
remodeling of the tunica media and intima characterized by gross
VSMC growth and disorganization including complete loss of elastic
lamellae.
Intimal hyperplasia assessment was graded as follows: 1no
VSMC infiltration between the endothelial basement membrane and
the internal elastic lamina; 2some evidence of VSMC or monocyte
infiltration in the tunica intima; 3moderate synthetic VSMC
content and inward distension of the intima; or 4gross synthetic
VSMC proliferation and monocyte/macrophage infiltration of the
intima leading to eccentric remodeling. Inflammatory cell assess-
ment was performed by counting the number of positively stained
cells in 1 whole cross section of the tunica media.
Immunochemical and histochemical staining for ET-1, ETA, ETB,
medionecrosis, and collagen presence was measured quantitatively
with image-analysis software connected to a light microscope. In the
case of Picrosirius-stained collagen, sections were imaged for total
collagen staining with standard light microscopy procedures and
additionally were imaged with polarized light microscopy to detect
variations in type 1 and 3 content. A Nikon Eclipse E600 (Nikon,
Tokyo, Japan) light microscope fitted with a Spot RT slider cooled
CCD camera (Diagnostic Instruments Inc, Sterling Heights, Mich)
captured digital images, which were then analyzed with Image Pro
Plus version 4.5.1.29 (Media Cybernetics, Silver Spring, Md).
Twenty fields were captured per slide at 200 magnification. The
border of the tunica media was traced and referred to as an area of
interest and measured in micrometers squared (Area A). Positive
areas of staining were then selected and independently calculated in
micrometers squared (Area B). To determine the percentage of
medial area of staining, the following calculation (Equation 1) was
applied:
(1) Percentage area of stainingarea Barea A100%
PCNA staining was determined as a percentage ratio of PCNA-
positive medial VSMCs to total medial VSMCs per field (Equation
2), for 20 fields at 200 magnification, as follows:
(2) Percentage PCNA positive cell countPCNA positivetotal cell count100%
Image Analysis Reproducibility
Reproducibility of quantitative image analysis studies was assessed
by measuring 15% of the total number of histology samples 3 times,
that is, at 3 different time points. Measurements were repeated with
the protocol described above for quantitative image analysis. The
average coefficient of variation for intraobserver variability was
determined to be 1.94%, where mean area percentage of staining for
repeat measures was 47.33%, 46.88%, and 46.49%.
Statistical Analysis
Data were analyzed with SPSS version 11.5 (SPSS Inc, Chicago, Ill).
Results are presented as meanSD, and comparisons between
control and CABG patient tissue sections were determined with a
Student t test, corrected for variance. Statistical significance was
assumed when P0.05. The correlation coefficient (r value) was
calculated when we reviewed associations between 2 data sets.
The authors had full access to the data and take full responsibility
for its integrity. All authors have read and agree to the manuscript as
written.
Results
Four distinct elastic patterns have been documented in the
IMA.1 These include the elastic pattern having 8 lamellae
(Figure 2A); elastomuscular pattern with from 5 to 7 lamellae
(Figure 2B); muscular type 1 (Figure 2C) with 3 to 4 irregular
lamellae, all inclusive of the internal and external elastic
lamellae; and muscular type 2, which has diffuse and disor-
ganized elastic fibers not including the internal and external
elastic lamina (Figure 2D). Only 2 CABG patients had
multiple specimens collected because of allowances in the
surgical procedure at the time. The first had a segment of
proximal right UIMA collected, and the other had a mid-
distal section collected in addition to the distal left UIMA. No
differences were noted in the elastic pattern between different
regions in these cases. No correlations were found to exist
between vascular remodeling variables and elastic pattern,
with r values of 0.009 and0.206 for intimal hyperplasia and
VSMC disorganization, respectively (Table 1).
The percentage area of medionecrosis as defined by Alcian
blue staining was quantitated for both CIMA and UIMA
sections. There was a significant increase (P0.0006) in the
area of medionecrosis in UIMA specimens (Figure 3A)
compared with the control vessels (Table 2). Furthermore, no
significant correlation was observed between age and per-
centage of area of medionecrosis in the control group
Figure 1. Control stained with hematoxylin and eosin (200),
demonstrating well-organized, circumferentially aligned VSMCs
in the tunica media, interspersed by multiple layers of elastic
lamellae (A). B, UIMA section with evidence of moderate medial
VSMC disorganization () combined with extensive elastic
lamellae disruption and fragmentation (	).
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(r0.458), which suggests that the higher average age of the
CABG group was not contributory to this result.
Immunohistochemical investigation of chronic inflamma-
tion in the IMA wall with a specific immunolabel for
monocytes and macrophages demonstrated a high variability
in the number of macrophages infiltrating the UIMA tunica
media, with a range from 0 to 203 in 1 whole-vessel cross
section. Although not statistically significant, twice as many
macrophages were present in the UIMA specimens as in
controls (9.829.5 versus 5.95.3, respectively). Mono-
cytes/macrophages in the tunica media of these vessels were
predominantly located at or near the medial/adventitial junc-
tion as opposed to the intimal/medial junction. Presence was
intense in the vasa vasorum and the adventitia, with a very
mild presence associated with the endothelium and subendo-
thelial regions (Figure 3B).
In the control and UIMA specimens, the adventitia was
dominated by thick, organized collagen fibers that were a
mixture of type 1 and type 3 fibers. The tunica media
consisted primarily of long, thin, well-organized type 3 fibers
that were organized concentrically within the elastic lamellae
(Figure 4A). Specimens collected from the CABG patients
also had a tunica media composed predominantly of type 3
collagen; however, there was also gross localization of thick,
disorganized type 1 fibers in some sections that was com-
monly associated with areas of intimal thickening (Figure
4B). Quantitative image analysis identified statistically sig-
nificant increases in total, type 3, and type 1 collagen area in
the tunica media of UIMA relative to CIMA (Table 2).
Abnormal and excessive VSMC growth is a feature of
atherogenesis, so PCNA was applied to assess cell cycling in the
tunica media (Figures 4C and 4D). The number of S-phase–
positive cells in the CABG patient group was 3 times greater
than in the CIMA specimens (P0.0001; Table 2).
ET-1 immunostaining localization in the CIMA and UIMA
was noted in luminal endothelial cells and vasa vasorum
(Figure 5A), VSMCs of the tunica media (Figure 5B) and
thickened intima (Figure 5C), fibroblasts in the adventitia,
and monocytes/macrophages in the vasa vasorum (Figure
5D). Quantitative image analysis of ET-1–stained area in the
tunica media of the UIMA was significantly greater than
control (Table 2). To account for any confounding acute
effects of the papaverine, the vasodilating agent used on the
IMA before grafting, a small subgroup of UIMAs were
collected before papaverine treatment. Interestingly, there
was a significant decrease in the percentage area of ET-1
labeling in the specimens collected after a 45-minute papav-
erine infusion with respect to those that were collected before
perfusion (42.9013.12% versus 52.077.27%, P0.005).
ETA receptor staining in both CIMA and UIMA sections
was principally located in the tunica media. Additionally,
positive staining was identified in adventitia (specifically,
fibroblasts and macrophages in this region) and also in the
vasa vasorum. Most noteworthy, though, was ETA localiza-
tion in the luminal endothelium (Figure 6A). When no
nuclear counterstain was applied, the nucleus labeled strongly
for the ETA receptor (Figure 6B, arrow), both in the medial
VSMCs and endothelial cells. Quantitative review of ETA
receptor area in the tunica media of CIMA and UIMA
sections demonstrated a significantly higher percentage area
of staining in the UIMA specimens (Table 2) than in control
specimens. ETB localization, as with the ETA receptor, also
produced some unexpected results in which staining appeared
to be associated with the connective tissue (specifically, the
Figure 2. An elastic CIMA stained with Alcian blue/
Verhoeff’s van Gieson (A), elastomuscular CIMA
(B), muscular type 1 CIMA section (C), and (D)
muscular type 2 vessel from a CABG patient. All
images 200.










Intimal hyperplasia 2.4 1.9 1.8 2.3 0.009
VSMC disorganization 2.7 2.6 2.4 2.3 0.206
No correlations were present when the pathological cellular remodeling variables were compared
with artery structure type.
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collagen fibers in the adventitia and in the media of both
control and patient vessels). Regions of intimal hyperplasia
and the luminal surface also stained strongly for ETB (Figure
6C). Quantitative assessment of ETB receptor presence was
significantly greater in the UIMA specimens than in CIMA,
although the nature of these receptors and how they may be
involved in pathological remodeling are uncertain given their
peculiar location (Table 2).
CABG patient risk factor demographics included hyperten-
sion, hyperlipidemia, diabetes mellitus, family history, and
cardiovascular history (Table 3). From this group, 8% of
patients were taking an ACE inhibitor at the time of surgery,
3% were taking a calcium channel blocker, 25% were taking
a -blocker, and 55% were taking various combinations of
the above.
Discussion
Although the IMA is generally considered to be a small
elastic artery, various histological patterns were observed in
this study, with a tendency for most specimens to fall into the
category referred to as elastomuscular. In the histological
investigations of the UIMA, no difference in the elastic
pattern was observed in the 2 cases in which multiple sections
were collected from different anatomic positions, that is, the
proximal right UIMA and distal left UIMA as well as the
mid-distal and distal left UIMA.
No trend was observed between increasing evidence of
intimal thickening or medial VSMC disorganization and
muscular histological pattern. Additionally, the presence of
medionecrosis was not age-dependent, because there was no
correlation between age and Alcian blue staining in the
controls (r0.458). Correlations between age and medione-
crosis were not investigated in the UIMA specimens because
hypertension, a significant factor in this group, is also
associated with medionecrosis and would therefore become a
confounding factor in the analysis. Contrary to Schlatmann
and Becker,22 who suggested that medionecrosis23 in the
vessel is not pathological and simply a phenomenon of aging,
medionecrosis in the UIMA tunica media of patients under-
going cardiac revascularization surgery was almost twice that
of the control specimens, 31.8514.52% versus
17.109.96% (P0.0006), respectively.
There was no significant monocyte or macrophage infil-
tration identified in the UIMA specimens (9.829.5) or in the
control specimens (5.95.3). Interestingly, infiltration of
monocytes/macrophages into the vessel wall did not appear to
be via the endothelium, because their presence was far greater
in the medial/adventitial junction and vasa vasorum.
Coupled with the medionecrosis, there were also signifi-
cant elevations in total, type 3, and type 1 collagen distribu-
tion within the tunica media of UIMA compared with the
CIMA (P0.0001, all respective comparisons). Although
both type 3 and type 1 collagens were elevated in CABG
patients, it is the increased deposition of type 1 collagen that
has been directly related to adverse pathological remodeling
and is indicative of severe fibrosis in the artery wall.
Remodeling of the extracellular matrix and vessel structure
is generally related to VSMC growth and proliferation,24
because VSMCs are known to manipulate their microenvi-
ronment as a result of mechanical and chemical stimuli.8 It is
not surprising given the significant fibrotic changes present
on average in the UIMA specimens that there were equally
apparent differences in the levels of VSMC growth in this
Figure 3. Medionecrosis in the UIMA wall (A) leading to frag-
mentation and loss of elastic lamellae and (B) macrophage infil-
tration in the tunica media via the adventitia. Images 400.
TABLE 2. Quantitative Analysis of Vascular Remodeling




(Area or Cell %)
UIMA
(Area or Cell %) P
Medionecrosis 17.109.96 31.859.96 0.0006
Total collagen 36.1210.48 65.6515.34 0.0001
Type 1 5.223.33 15.188.50 0.0001
Type 3 20.146.61 32.3911.31 0.0001
PCNA 11.068.18 37.2912.88 0.0001
ET-1 8.568.42 46.2718.46 0.0001
ETA (n24) 18.587.65 46.8811.52 0.0001
ETB (n19) 34.735.20 42.987.08 0.0067
Pathological structural, extracellular, and growth markers were all signifi-
cantly elevated in the CABG patient artery tissue compared with control
specimens.
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group with respect to CIMA. PCNA immunolabeling was
more than 3 times greater in the UIMA VSMCs
(37.2912.88%) than in controls (11.068.18%).
In normal human arteries, ET-1 protein expression is
localized to luminal endothelial cells25; however, in active
coronary and aortic atherosclerotic plaque, ET-1 immunore-
activity is associated with areas of extensive macrophage
infiltration,26 as well as endothelial cells and VSMCs,27
respectively. In the present study, ET-1 presence was noted in
endothelial cells, VSMCs, fibroblasts, and macrophages, as
well as endothelial cells of the vasa vasorum and neutrophils.
Staining intensity overall was strongest in the fibroblasts and
inflammatory cell types, with consistently moderate to strong
ET-1 presence in the IMA VSMC nuclei and, to a lesser
extent, albeit more diffusely, in the cytoplasmic area of the
VSMCs and endothelium. The percentage area of ET-1 was
significantly higher in the UIMA specimens (46.2718.46%
versus 8.568.42%, P0.0001). Additionally, patients
whose UIMA was dilated with the vasorelaxant drug papav-
erine had a 10% decrease in endogenous ET-1 expression
from the tunica media (P0.005) compared with those
vessels that were collected before papaverine infusion.
Hence, papaverine stimulation may interfere with acute ET-1
expression by increasing endothelium-independent nitric ox-
ide levels.
Plasma ET-1 has been reportedly increased in subarach-
noid hemorrhage28 and has been suggested to be a major
cause of cerebral vasospasm afterward. Despite subarachnoid
hemorrhage being the leading cause of death in the control
group, it is unlikely that this would have influenced levels of
in situ ET-1 in the CIMA owing to the rapid onset of this
condition.
ETA receptors are known to exist in both healthy and
atherosclerotic vessels, and physiologically, they are impor-
tant in maintaining vascular function. However, in patholog-
ical conditions such as atherosclerosis, elevations in ETA
subtype density have been implicated, with disease progres-
sion resulting from its contribution to VSMC mitogene-
Figure 4. IMA collagen profiles in a CIMA (A,
200) and UIMA (B, 200) where long, thin, wavy
fibers as opposed to thick, disorganized collagen
structures are apparent, respectively. PCNA label-
ing indicates VSMC cycling in a CIMA section (C,
200) and UIMA (D, 400).
Figure 5. ET-1 expression was noted in the vasa
vasorum (A, 400), luminal endothelium and tunica
media VSMCs (B, 200); areas of intimal hyperpla-
sia in a UIMA specimen (C, 200); fibroblasts (‡)
and macrophages (§) in the adventitia (D, 400).
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sis.29,30 In vivo models have indicated that ETA receptor
signaling is directly involved in mediating ischemia in ad-
vanced atherosclerosis and that ETA receptor antagonism
could prevent myocardial infarction.31 Importantly, Barton et
al32 have demonstrated that long-term ETA blockade reduces
the development of atheroma independently of serum choles-
terol and blood pressure changes using an apolipoprotein
E–deficient murine model.
ETA receptor area in the tunica media of the UIMA sections
was highly elevated compared with the control
(46.8811.52% versus 18.587.65%; P0.0001, respec-
tively). ETA localization was apparent in chronic inflamma-
tory cells and fibroblasts. ETA receptors were present in the
mammary endothelial cells of the lumen and vasa vasorum,
which has not been reported previously. In particular, ETA
receptors were observed on the nuclear surface of VSMCs in
the IMA tunica media, which suggests the effect of ET-1
stimulation is both cellular and nuclear.
Staining for ETB presence was highly unusual and pro-
duced some unexpected findings in that this receptor subtype
appeared to be colocalized to the connective tissue in the
media and adventitia. Areas of intimal hyperplasia commonly
included strong collagen type 1 staining and also had an
increased presence of ETB receptors. ETB receptor labeling
area was significantly elevated in the UIMA compared with
the control tissue (P0.0067). There are some authors who
have suggested this receptor subtype is equal to or more
important in neointimal formation than the ETA receptor.17
ETB area was not assessed in the tunica intima because the
CIMA had no evidence of intimal thickening, whereas a
reasonable number of UIMAs had some degree of intimal
hyperplasia. Additionally, of the UIMA specimens that were
assessed, strong ETB staining was apparent in areas of mild to
moderate intimal hyperplasia. Therefore, it is probably a
marker that should be considered equally as important as the
ETA receptor in terms of its potential contribution to the
development of atherogenesis.
Consideration should be given to the fact that the vast
majority of the patient cohort was taking either an ACE
inhibitor or a -blocker, in addition to statin therapy. ACE
inhibitors and statins have been documented to inhibit
ET-1 expression in in vivo33 and in vitro models,34
respectively. These results are not in agreement with the
present findings; however, in other research, we have
demonstrated that plasma ET-1 is not different between a
CABG patient group and a control group,35 which poten-
tially reflects the fact that these medications affect the
level of circulating ET-1 but not the more chronic and
stable source present in the tunica media.
Conclusions
This study is novel for multiple reasons, because it has
combined an in-depth review of UIMA histology and quan-
titatively assessed pathological remodeling variables with
ET-1, ETA, and ETB receptor expression in this unique vessel.
Although the IMA was originally considered to a passive
conduit, these histological findings concur with physiological
studies that indicate this artery is strongly responsive to
Figure 6. A, ETA receptor expression in the UIMA
tunica media and endothelium (200); B, nuclear
ETA expression in UIMA VSMCs (arrow) and in the
endothelium (1000); C, UIMA ETB expression
demonstrating strong staining of connective tissue
structures (arrow, 200); and D, rabbit IgG control
(200).
TABLE 3. CABG Patient Risk Factor Status
Risk Factor/Comorbidity






Diabetes mellitus, type 1 5
Diabetes mellitus, type 2 31
Family history of CVD 71
CVD history 87
CVD indicates cardiovascular disease.
CVD history included angina, acute myocardial infarction, previous CABG or
angioplasty, cerebrovascular accident, transient ischemic attack, or carotid
atherosclerotic disease. Family history of CVD was defined as the occurrence
of either a cerebrovascular accident or acute myocardial infarction event in a
biological parent under the age of 65 years.
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exogenous vasoactive peptides, particularly ET-1. High en-
dogenous levels of ET-1 peptide expression and ETA/B recep-
tor presence, coupled with pathological cellular and extracel-
lular remodeling in the vascular tissue of patients with severe
ischemic heart disease, are related to deleterious processes
that are essentially a prelude to atherosclerosis. Hence, this
research supports previous findings that ET-1 is a strong
preatherogenic marker of abnormal vascular function and that
the elevated presence of both receptor types suggests that the
clinical use of endothelin receptor antagonists in high-risk
groups may prevent pathological tissue remodeling that
results from elevated ET-1 expression in ischemic heart
disease, pulmonary hypertension, and congestive heart
failure.
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CLINICAL PERSPECTIVE
Endothelin-1 (ET-1), a vasoconstricting mitogen, is ubiquitously expressed by the vascular endothelium, where the
majority of the secreted peptide is released abluminally, binding to the endothelin A receptor subtype (ETA) in the tunica
media of the artery and thus mediating vasoconstriction. This system starts to go amiss when vascular smooth muscle cells
(VSMCs) in the wall of the vessel start to synthesize and express ET-1, which generally acts in an autocrine/paracrine
manner. It is the upregulation of ET-1 and angiotensin II as a result of chronic mechanical and/or chemical trauma to the
vessel wall that has been suggested to activate the deleterious mechanisms that lead to abnormal VSMC growth or
dedifferentiation. This report reviews the histopathology of the internal mammary artery graft in CABG patients and a
control group. It specifically investigates the associations between cellular and structural pathological remodeling
parameters and ET-1. In particular, we have identified increased levels of VSMC cycling and collagen deposition in the
ungrafted internal mammary artery from the CABG patients, in conjunction with significant elevations of ET-1 expression
in the tunica media. These changes in VSMC growth behavior, coupled with remodeling of the extracellular matrix, are
characteristic of hypertension and predispose to atherogenesis.
1188 Circulation March 7, 2006
 by guest on February 10, 2014http://circ.ahajournals.org/Downloaded from 
